Nurdiana Nordin received her B.Sc. in pure chemistry from the University of Malaya, Kuala Lumpur, Malaysia in 2012 and completed her M.Sc. from the same university in organic synthesis and computational chemistry in 2015 under the SLAB scholarship. After graduation, she joined the Institute of Microstructure Technology (IMT) at the Karlsruhe Institute of Technology (KIT) in Karlsruhe, Germany, in 2016 under the supervision of Dr. Neil MacKinnon and Dr. Vlad Badilita in the group of Prof. Jan G. Korvink. At the same time, she also joined the Bio-Interfaces Graduate International School (BIF-IGS) at the Institut für Biologische Grenzflächen, IBG. She received her Ph.D. from BIF-IGS and the Fakultät für Maschinenbau, KIT in 2020. In Karlsruhe, she was trained in nuclear magnetic resonance (NMR) technology and clean room fabrication of microfluidic device processes. She also had the opportunity to visit the Bruker company, where the NMR devices are manufactured. She had extensive laboratory work that included electrochemical systems, microfluidic fabrication processes, bio-organic synthesis, and the NMR techniques. To pursue her interest further, she modified the microfluidic platform compatible with µ-NMR system to monitor the activity of simple metabolic pathway reaction. She has also recently joined the Department of Chemistry, University of Malaya as a Senior Lecturer. Her research interests include NMR development, catalyst modification, multiplex enzyme activity, bio-organic mechanisms, biomedical microsystems (BioMEMS), electrochemistry and metabolomic studies.
show more »Dr David Lee Dai Wee is a consultant clinical oncologist at the University of Malaya Medical Centre and lecturer at the Faculty of Medicine, University of Malaya. He received his undergraduate medical education at International Medical University (IMU), Malaysia, and subsequently Master of Clinical Oncology at the University of Malaya in 2020. Dr Lee also holds FRCR (Clinical Oncology) since 2022. He completed a fellowship in experimental therapeutics under guidance of Dr Daniel Tan at the National Cancer Centre Singapore, involving in the conduct of more than 40 early-phase clinical trials. He is the principle investigator for various international multicenter clinical trials, focusing on early-phase studies, thoracic cancers, and head and neck cancers. Dr Lee is the inaugural recipient of the American Society of Clinical Oncology (ASCO) Leadership Development Program - Asia Pacific award in 2021-2022. He received the ASCO International Development and Education Award (IDEA) in 2024, and IASLC Academy Award 2024. Currently Dr Lee serves in the ASCO Membership Advisory Group, IASLC Multidisciplinary Clinical Science Committee and FARO Council.
show more »Dr. Seong Lin DING is Associate Professor of Sociolinguistics at the Faculty of Languages and Linguistics, University of Malaya. She was formerly an OeAD scholar and a Korean Foundation for Advanced Studies Fellow. She has held visiting positions at the University of Manchester (UK), Lancaster University (UK), Hong Kong Polytechnic University (HK), Yonsei University (South Korea), and University of Glamorgan (University of South Wales, UK). She has also been invited to present lectures and seminars at the University of Zadar (Croatia), University of Graz (Austria), and National Cheng Kung University (Taiwan). Her research focuses on minority/heritage languages and communities. She is also interested in sociology of education, language and identity, and linguistic landscape. Her academic articles have appeared in leading journals in linguistics (e.g., Applied Linguistics Review; Current Issues in Language Planning; International Journal of Bilingualism; International Journal of Heritage Studies; Language in Society; Lingua; Multilingua; Social Semiotics), and educational research (e.g., Australasian Journal of Educational Technology; Educational Technology Research and Development; Innovations in Education and Teaching International). She particularly welcomes opportunities for interdisciplinary collaborations with researchers of shared interests in the area of heritage/minority language and migration.
show more »RECENT PUBLICATION
-
Almayahi, Basim A.; Sani, Siti F. Abdul; Tajuddin, Hairul A.; Saad, Hazwani Mat; Alhasan, Ammar; Sim, Kae Shin (2025). Structural and Functional Characterization of Gamma-Irradiation-Enhanced Nanocomposites for Colorectal Cancer Therapy. Journal of Molecular Structure
-
Farhana, N. K.; Pershaanaa, M.; Kamarulazam, Fathiah; Saidi, Norshahirah M.; Bashir, Shahid; Ramesh, S.; Ramesh, K. (2025). A Polysaccharide Extracted from Guar Beans-Based Gel Polymer Electrolytes for Efficient Dye-Sensitized Solar Cells. Journal of Photochemistry and Photobiology a-Chemistry
-
Hidayat, Ahmad Fadhlurrahman Ahmad; Mohamad, Saharuddin B.; Tayyab, Saad; Harun, Wan Himratul Aznita Wan; Abd Halim, Adyani Azizah (2025). Molecular Interaction of a Protease Inhibitor, Leupeptin, With Human Serum Albumin: Insights from Calorimetry, Spectroscopy, Microscopy, and Computational Approaches. Journal of Molecular Structure
-
Adam, Hussaini; Gopinath, Subash C. B.; Krishnan, Hemavathi; Adam, Tijjani; Fakhri, Makram A.; Salim, Evan T.; Shamsher, A.; Subramaniam, Sreeramanan; Chen, Yeng (2025). Selective Detection of Alpha Synuclein Amyloid Fibrils by Faradaic and Non-Faradaic Electrochemical Impedance Spectroscopic Approaches. Bioelectrochemistry
-
Ng, Min Phin; Chan, Wei Chuen; Li Tan, Min; Tan, Chun Hoe; Tiong, Sheena Yin Xin; Sim, Kae Shin; Tan, Kong Wai (2025). Sialic Acid Detection and Theranostic Activity of Phenylboronic Acid-Based Fluorescent Probe in Human Colorectal Adenocarcinoma Ht-29 Cells. Spectrochimica Acta Part a-Molecular and Biomolecular Spectroscopy
TOTAL PUBLICATIONS AS OF DATE 51
LATEST AWARDED GRANT
-
UM-Ummc Rebung Train-The-Trainer Community Nurse Competency Program for Cancer
-
Plastic-Eater
-
Sustainability of Early Cancer Diagnosis Ecosystem Using Rebung Training Programs
-
Ra.Kan Ku Goes Pro
-
Seagrass Mapping and Community-Based Programme
-
Youth Empowerment & Sustainability (Yes) Program 2.0
-
Driving Change: Empowering Primary Healthcare Providers for Early Cancer Detection and Navigation
-
Pills to Art